Systematic review of 14 placebo-controlled RCTs (most post hoc analyses) in perianal fistulizing Crohn's: advanced therapies were associated with higher induction fistula response (RR 1.65) and remission (RR 1.91); infliximab effective; evidence for others limited.
Meta-analysisn = 14 trials
Yuan et al. Biologics and small molecules for perianal Crohn's disease: a systematic review and meta-analyses of randomized placebo-controlled trials